StarStarter Rx
Phase 2- Indications
- Social anxiety disorder
Company intelligence / Profile preview
Arcade Therapeutics has demonstrated robust reductions in social anxiety symptoms in adults through its flagship game-based digital therapeutic "StarStarter Rx," validated by multiple randomized controlled trials. The company is preparing for FDA submission of its prescription digital therapeutics pipeline targeting a range of mental health conditions. Their approach leverages attention bias modification delivered via engaging mobile games, with clinical data showing reductions in self-reported anxiety, stress hormone cortisol levels, and cognitive signs of distress.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arcade Therapeutics.